German-based labelling specialist Schreiner MediPharm has conducted further tests on its tamper-proof tailored void labels for pharmaceutical packaging.
The company states that following extensive tests, the closure seals can be adapted to the relevant packaging, material, substrate, and application.
They also have the option of integrating a tab.
The Void-Labels are intended to be utilised as a tool against the counterfeit medicines market, which Schreiner states amounts to $200m and grows by 20% every year. The labels reportedly make it difficult for counterfeiters to reuse original medicinal packaging.
The seals can be customised and are available in a variety of colours, including transparent versions. They can be used for glass and plastic packaging and come in no-transfer, semi-transfer, and full-transfer options.
Schreiner MediPharm asserts that the Void-Labels can also provide proof of authenticity.
The European Union (EU) updated the Falsified Medicines Directive for pharmaceutical packaging in 2019. This includes obligatory safety features and an EU-wide logo for identification.
A GlobalData report identifies blockchain technology as a further protectant against the counterfeit medicines market as a means of sharing data and tracing supply chains.
Schreiner MediPharm’s smart vial kit was released in 2019 and was designed to enable the electronic tracking of dispensed medicines.